Join us, TMA's WomenWithIBM Affinity Group, for a timely conversation on Abcuro’s newly-released topline results from the MUSCLE study of ulviprubart (ABC008) for Inclusion Body Myositis. OPEN TO ALL. Dr. Namita Goyal, Principal Investigator, will explain what the findings show and what’s ahead after the data is presented at the 6th Global Conference on Myositis...

For many living with Inclusion Body Myositis, changes in speech and swallowing can be among the most isolating — and least talked about — challenges of the disease. Join us for a special two-part symposium this April and May, bringing together leading experts from Johns Hopkins to shed light on the speech and swallowing issues...

For many living with Inclusion Body Myositis, changes in speech and swallowing can be among the most isolating — and least talked about — challenges of the disease. Join us for the second part of this two-part symposium this May (Part 1 will be available on our YouTube Channel by May 1), bringing together leading...